Life and death in cancer: GADD45 α and γ are critical regulators of NF-κB mediated escape from programmed cell death

Cell Cycle

Volumn 4, Issue 1, 2005, Pages 18-20

  Zerbini, Luiz F ^a   Libermann, Towia A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Apoptosis; C myc; Cancer; GADD45; I B; JNK; NF B

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; REGULATOR GENE; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 22844432024     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.1.1363     Document Type: Short Survey

References (23)

1. Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol 2002; 2:725-34.
2. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2002; 2:301-10.
3. Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto K, Libermann TA, Anderson KC. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-κ B. Blood 1996; 87:1104-12.
4. Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, Marumo K, Shimizu N, Murai M. Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 2003; 24:377-84.
5. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF- κB. J Clin Inves 2001; 107:241-6.
6. De Martin R., Schmid JA, Hofer-Warbinek R. The NF-κB/Rel family of transcription factors in oncogenic transformation and apoptosis. Mutat Res 1999; 437:231-43.
7. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-60.
8. Grilli M, Memo M. Nuclear factor-κB/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol 1999; 57:1-7.
9. Zerbini LF, Wang Y, Cho JY, Libermann TA. Constitutive activation of nuclear factor κB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res 2003; 63:2206-15.
10. Stoffel A, Levine AJ. Actvation of NF-κB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: A directional link between NF-κB and p53. Cell Cycle 2004; 8:1017-20.
11. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-B. Nature 1995; 376:167-9.
12. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science 1996; 274:787-9.
13. Liu ZG, Hu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996; 87:565-76.
14. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000; 288:870-4.
15. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380: 75-9.
16. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature 2001; 414: 313-7.
17. Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E, Cox LS. Characterisation of the interaction between PCNA and Gadd45. Oncogene 1995; 10:2427-33.
18. Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace Jr AJ and O'Connor PM. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 1996; 12:595-607.
19. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 2001; 15:308-13.
20. Amanullah A, Azam N, Balliet A, Hollander C, Hoffman B, Fornace A, Liebermann D. Cell signalling: cell survival and a Gadd45-factor deficiency. Nature 2003; 14:741.
21. Mita H, Tsutsui J, Takekawa M, Witten EA, Saito H. Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol Cell Biol 2002; 22:4544-55.
22. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. NF-κB and JNK: An intricate affair. Cell Cycle 2004; In press.
23. Zerbini LF, Wang Y, Czibere A, Correa RG, Cho JY, Ijiri K, Wei W, Joseph M, Gu X, Grall F, Goldring MB, Zhou JR, Libermann TA. NF-κB mediated repression of GADD45α and γ is essential for cancer cell survival. Proc Natl Acad Sci USA 2004; 101:13618-23.